Modus Therapeutics Holding AB (publ) (STO:MODTX)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.289
-0.002 (-0.69%)
At close: Mar 6, 2026

STO:MODTX Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2018
Selling, General & Admin
7.326.737.836.997.09
Upgrade
Research & Development
10.859.078.4810.913.54
Upgrade
Other Operating Expenses
-0.020.040.090.120.05
Upgrade
Operating Expenses
18.1415.8416.418.0120.69
Upgrade
Operating Income
-18.14-15.84-16.4-18.01-20.69
Upgrade
Interest Expense
---1.5-0.31-0
Upgrade
Interest & Investment Income
-0.290--
Upgrade
Other Non Operating Income (Expenses)
-0.4--0--
Upgrade
Pretax Income
-18.54-15.55-17.9-18.32-20.69
Upgrade
Net Income
-18.54-15.55-17.9-18.32-20.69
Upgrade
Net Income to Common
-18.54-15.55-17.9-18.32-20.69
Upgrade
Shares Outstanding (Basic)
6236181612
Upgrade
Shares Outstanding (Diluted)
6236181612
Upgrade
Shares Change (YoY)
71.99%102.53%10.22%30.09%109.34%
Upgrade
EPS (Basic)
-0.30-0.43-1.01-1.14-1.67
Upgrade
EPS (Diluted)
-0.30-0.43-1.01-1.14-1.67
Upgrade
EBIT
-18.14-15.84-16.4-18.01-20.69
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.